Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Color Vision Loss Progression in IRD Patients: Retinal Structural Changes Correlations, and a Novel Color Discrimination Test for Extreme Low Vision Patients

NCT07085533 is registered in ClinicalTrials.gov with Zhongmou Therapeutics as lead sponsor.

NCT NCT07085533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07085533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Color Vision Loss Progression in IRD Patients: Retinal Structural Changes Correlations, and a Novel Color Discrimination Test for Extreme Low Vision Patients
Lead sponsor
Zhongmou Therapeutics
Phase
Observational
Overall status
Recruiting
Start date
July 20, 2025
Completion date
September 28, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

achromatopsia, color vision defects, genotype, macular degeneration, mutation, optical coherence tomography (oct), phenotype, retinal dystrophies, vision disorders, visual acuity